Comparison of the analgesic efficacy of intravenous morphine infusion and transdermal fentanyl in oncology patients with mucositis;Mukozi̇tli̇ onkoloji̇ hastalarinda i̇ntravenöz morfi̇n i̇nfüzyonu ve transdermal fentani̇li̇n analjezi̇k etki̇nli̇ǧi̇ni̇n karşilaştirilmasi

Anatolian Journal of Clinical Investigation

Volumn 4, Issue 3, 2010, Pages 134-140

  Ergenoǧlu, Pinar ^a   Özbek, Hayri ^b   Gündüz, Murat ^b   Işik, Geylan ^b  

^a Ba kent Üniversitesi Tip Fakültesi Anesteziyoloji ve Reanimasyon AD   (United Kingdom)

^b Çukurova Üniversitesi Anesteziyoloji ve Reanimasyon AD   (United Kingdom)

Author keywords

Analgesia; Cancer; Morphine; Oral mucositis; Transdermal fentanyl

Indexed keywords

ANTINEOPLASTIC AGENT; FENTANYL; MORPHINE;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ANESTHESIA LEVEL; ARTICLE; BRADYCARDIA; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOTENSION; MALE; MOUTH PAIN; MUCOSA INFLAMMATION; NAUSEA; PAIN ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEX RATIO; URINE RETENTION; VISUAL ANALOG SCALE; VOMITING;

EID: 77957986543     PISSN: 13068814     EISSN: 13071173     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Redding SW. Cancer therapy-related oral mucositis. J Dent Educ 2005;69(8):919-929.
2. Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1999;17(8):2412-2418.
3. Blijlevens NMA. Implications of treatment-induced mucosal barrier injury. Current opinion in oncology 2005;17(6):605-610.
4. Naidu MUR, Ramana GV, Rani PU, et al. Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. Neoplasia (New York, N.Y.) 2004;6(5):423-431.
5. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head & neck 2004;26(1):77-84.
6. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, andmanagement. Oncology (Williston Park, N.Y.) 2003;17(12):1767-79.
7. Demarosi F, Lodi G, Soligo D, et al. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone marrow transplantation 2004;33(12):1247-1251.
8. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100(9 Suppl):2026-2046.
9. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone marrow transplantation 2001;27 Suppl 2:S3-S11.
10. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA: a cancer journal for clinicians 2001;51(5):290-315.
11. Mercadante S, Fulfaro F. World Health Organization guidelines for cancer pain: a reappraisal. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 2005;16 Suppl 4:iv132-iv135.
12. Hill HF, Chapman CR, Kornell JA, et al. Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 1990;40(2):121-129.
13. Mackie AM, Coda BC, Hill HF. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 1991;46(3):265-269.
14. Hill HF, Coda BA, Mackie AM, Iverson K. Patient-controlled analgesic infusions: alfentanil versus morphine. Pain 1992;49(3):301-310.
15. Coda BA, O'Sullivan B, Donaldson G, et al. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997;72(3):333-346.
16. Dunbar PJ, Chapman CR, Buckley FP, Gavrin JR. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain 1996;68(2-3):265-270.
17. Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997;53(1):109-138.
18. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996;64(3):527-534.
19. Kim JG, Sohn SK, Kim DH, et al. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplantation proceedings 2005;37(10):4488-4491.